Tri Chemical Laboratories Inc.

As of July 31, 2026, Tri Chemical Laboratories Inc. carries a market capitalization of 105.45B, placing it among publicly traded companies globally. Its enterprise value stands at 101.16B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Tri Chemical Laboratories Inc.'s next confirmed earnings release is scheduled for November 30, 2026.

As of July 31, 2026, Tri Chemical Laboratories Inc. has 32.50M shares outstanding.

These figures are as of July 31, 2026.

As of July 31, 2026, Tri Chemical Laboratories Inc. maintains a current ratio of 4.37, meaning it holds 4.4x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended July 31, 2026.

As of the close on October 23, 2026, Tri Chemical Laboratories Inc.'s stock has gained approximately 3.33% over the past 52 weeks. The 50-day moving average sits at 3,160.60, while the 200-day moving average is 3,263.90.

As of July 31, 2026, Tri Chemical Laboratories Inc. holds 10.08B in cash and equivalents against 5.78B in total debt, resulting in a net debt position of -4.30B. Total book value stands at 38.25B, with working capital of 18.85B providing operational flexibility.

Tri Chemical Laboratories Inc.'s most recent stock split took place on January 28, 2021 with a 1:4 split ratio.